Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 13

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor

Total article views   HTML views PDF downloads Totals
11,941 Dovepress* 11,018+ 479 11,497
PubMed Central* 923 243 1,166
Totals 11,941 722 12,663
*Since 18 August 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar